June 9, 2020 / 4:16 PM / a month ago

BRIEF-Guerbet: National Medical Products Administration Approves Lipiodol Ultra-Fluid in China

June 9 (Reuters) - GUERBET SA:

* NATIONAL MEDICAL PRODUCTS ADMINISTRATION APPROVES LIPIODOL® ULTRA-FLUID FOR TRANS-ARTERIAL CHEMOEMBOLIZATION OF INTERMEDIATE STAGE HEPATOCELLULAR CARCINOMA (HCC) IN ADULT PATIENTS IN CHINA Source text: bit.ly/2Uq1CpM Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below